Washington University School of Medicine in St. Louis has received a three-year, $4.5 million grant from the Carol and Gene Ludwig Family Foundation, aimed at advancing research on neuroimmunology and neurodegeneration with the ultimate goal of developing new treatments for Alzheimer’s disease. Administered by WashU Medicine’s Brain Immunology & Glia (BIG) Center, the Carol and Gene Ludwig Initiative in Neuroimmunology Research will support innovative projects led by David M. Holtzman, MD; Jonathan Kipnis, PhD; and Marco Colonna, MD, in addition to other faculty members through a seed grant program.
$4.5 million supports pathbreaking neuroimmunology research
View Content